Cambridge, MA, United States of America

Dyuti Majumdar

USPTO Granted Patents = 7 


 

Average Co-Inventor Count = 10.1

ph-index = 2

Forward Citations = 10(Granted Patents)


Location History:

  • Milford, CT (US) (2007)
  • Cambridge, MA (US) (2010 - 2024)

Company Filing History:


Years Active: 2007-2024

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):

Title: **Dyuti Majumdar: Innovator in Pharmaceutical Compounds**

Introduction

Dyuti Majumdar is a prominent inventor based in Cambridge, MA, known for his significant contributions to the field of pharmaceuticals. With seven patents to his name, he has been instrumental in developing compounds that target specific biological processes, particularly those related to the inhibition of SHP2 activity.

Latest Patents

One of Dyuti Majumdar's latest patents focuses on "Compounds and compositions for inhibiting the activity of SHP2." This invention details compounds defined by a specific formula that are capable of inhibiting SHP2, which is crucial in various disease management strategies. The patent also outlines a process for the preparation of these compounds, along with pharmaceutical preparations that incorporate them and methods of using these innovations to address disorders associated with aberrant SHP2 activity.

Career Highlights

Throughout his career, Dyuti has contributed to leading pharmaceutical companies, including Novartis AG and Bayer Pharmaceuticals Corporation. His work in these organizations has allowed him to explore and innovate within the realm of pharmaceutical research and development, further establishing his reputation as an inventor.

Collaborations

Dyuti Majumdar has collaborated with notable colleagues in the industry, including Joachim Rudolph and Louis-David Cantin. These partnerships have facilitated the exchange of ideas and expertise, driving forward the advancements in his research projects and fostering innovative solutions.

Conclusion

Dyuti Majumdar exemplifies the impact inventors can have in the pharmaceutical industry through targeted innovations. His patents continue to shape the landscape of drug development, underscoring the importance of research and collaboration in addressing complex medical challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…